Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis
Results of this study suggest that a multivariable risk score that uses routinely available clinical data outperforms FIB-4 alone in identifying patients at risk of HCC who do not have viral hepatitis or hepatic decompensation at baseline.
Authors
- Joseph K. Lim (ORCID: https://orcid.org/0000-0003-1126-8128)
- Tamar H. Taddei (ORCID: https://orcid.org/0000-0002-6500-1739)
- Amy C. Justice (ORCID: https://orcid.org/0000-0003-0139-5502)
- Kirsha S. Gordon (ORCID: https://orcid.org/0000-0002-4925-1914)
- Ysabel C. Ilagan‐Ying (ORCID: https://orcid.org/0000-0002-4503-5368)
- Vincent Lo Re (ORCID: https://orcid.org/0000-0001-7955-0600)
- Jessie Torgersen (ORCID: https://orcid.org/0000-0002-7861-1421)
- Janet P. Tate
Institutions
- Yale University (US)
- VA Connecticut Healthcare System (US)
- Yale New Haven Health System (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.43608
- Citations
- 12
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.64